$585 Million is the total value of NORTH TIDE CAPITAL, LLC's 15 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 47.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SEM | Sell | SELECT MED HLDGS CORP | $132,500,000 | -25.1% | 10,000,000 | -23.7% | 22.65% | +17.7% |
HWAY | HEALTHWAYS INC | $102,375,000 | -14.0% | 4,500,000 | 0.0% | 17.50% | +35.0% | |
SVU | Sell | SUPERVALU INC | $86,255,000 | -29.4% | 18,469,921 | -24.6% | 14.75% | +10.8% |
GILD | Sell | GILEAD SCIENCES INC | $35,805,000 | -43.4% | 500,000 | -37.5% | 6.12% | -11.2% |
KND | Buy | KINDRED HEALTHCARE INC | $33,363,000 | -18.4% | 4,250,000 | +6.2% | 5.70% | +28.2% |
ELOS | SYNERON MEDICAL LTD | $29,400,000 | +17.3% | 3,500,000 | 0.0% | 5.03% | +84.2% | |
MYL | Sell | MYLAN N V | $28,613,000 | -62.5% | 750,000 | -62.5% | 4.89% | -41.1% |
IPXL | New | IMPAX LABORATORIES INC | $26,500,000 | – | 2,000,000 | +100.0% | 4.53% | – |
LPNT | Sell | LIFEPOINT HEALTH INC | $22,720,000 | -23.3% | 400,000 | -20.0% | 3.88% | +20.5% |
AGN | New | ALLERGAN PLC | $21,001,000 | – | 100,000 | +100.0% | 3.59% | – |
MYGN | Buy | MYRIAD GENETICS INC | $19,171,000 | -6.8% | 1,150,000 | +15.0% | 3.28% | +46.3% |
QHCCQ | QUORUM HEALTH CORP | $18,175,000 | +15.9% | 2,500,000 | 0.0% | 3.11% | +82.1% | |
VVUS | VIVUS INC | $15,626,000 | +0.9% | 13,587,460 | 0.0% | 2.67% | +58.4% | |
BIOS | BIOSCRIP INC | $8,840,000 | -64.0% | 8,500,000 | 0.0% | 1.51% | -43.5% | |
ARAY | New | ACCURAY INC | $4,600,000 | – | 1,000,000 | +100.0% | 0.79% | – |
ADUS | Exit | ADDUS HOMECARE CORP | $0 | – | -174,079 | -100.0% | -0.50% | – |
AFAM | Exit | ALMOST FAMILY INC | $0 | – | -700,000 | -100.0% | -2.80% | – |
PRGO | Exit | PERRIGO CO PLC | $0 | – | -500,000 | -100.0% | -5.03% | – |
VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -2,000,000 | -100.0% | -5.34% | – |
CYH | Exit | COMMUNITY HEALTH SYS INC NEW | $0 | – | -5,500,000 | -100.0% | -6.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SELECT MED HLDGS CORP | 18 | Q3 2017 | 22.7% |
SUPERVALU INC | 17 | Q2 2017 | 15.0% |
SYNERON MEDICAL LTD | 16 | Q1 2017 | 5.0% |
HEALTHWAYS INC | 15 | Q4 2016 | 17.5% |
KINDRED HEALTHCARE INC | 14 | Q4 2016 | 11.0% |
ALMOST FAMILY INC | 14 | Q3 2016 | 5.9% |
VIVUS INC | 13 | Q2 2017 | 3.3% |
TEVA PHARMACEUTICAL INDS LTD | 12 | Q1 2016 | 13.4% |
AMEDISYS INC | 12 | Q1 2016 | 13.2% |
MYLAN N V | 11 | Q3 2017 | 14.0% |
View NORTH TIDE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
IRIDEX CORP | February 16, 2021 | 760,069 | 5.5% |
BioScrip, Inc.Sold out | February 01, 2018 | 0 | 0.0% |
TIVITY HEALTH, INC. | August 02, 2017 | 450,000 | 1.1% |
AMEDISYS INC | January 22, 2016 | 1,382,388 | 4.1% |
HEALTHWAYS, INC | November 12, 2015 | 4,080,573 | 11.3% |
ALMOST FAMILY INC | January 12, 2015 | 1,078,750 | 11.4% |
VIVUS INC | January 05, 2015 | 10,150,000 | 9.8% |
KINDRED HEALTHCARE, INC | October 10, 2014 | 3,390,000 | 5.2% |
ORTHOFIX INTERNATIONAL N V | April 04, 2014 | 980,100 | 5.4% |
Syneron Medical Ltd. | February 14, 2014 | 2,000,000 | 5.7% |
View NORTH TIDE CAPITAL, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2021-02-16 |
SC 13G/A | 2018-02-01 |
13F-HR | 2017-11-14 |
13F-HR | 2017-08-14 |
SC 13D/A | 2017-08-02 |
13F-HR | 2017-05-15 |
4 | 2017-03-20 |
4 | 2017-03-10 |
4 | 2017-03-07 |
4 | 2017-03-02 |
View NORTH TIDE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.